ClinicalTrials.Veeva

Menu

Mucosal Pressure of the Laryngeal Mask Airway Supreme Versus the i-Gel in Paralyzed Anesthetized Female Patients

S

Schulthess Klinik

Status

Completed

Conditions

Complication of Device Insertion
Device Induced Injury
Necrosis, Pressure
Airway Morbidity

Treatments

Device: Laryngeal Mask Airway Supreme
Device: i-Gel extraglottic airway device

Study type

Interventional

Funder types

Other

Identifiers

NCT01367678
Schulthess_Anä_1

Details and patient eligibility

About

In the following randomized non-crossover study, the investigators test the hypothesis that directly measured mucosal pressure differ between the laryngeal mask airway (LMA) Supreme and the i-Gel in paralyzed anesthetized females.

Thirty females aged 19-65 years were randomly allocated to receive either the size 4 LMA Supreme or i-Gel for airway management. Microchip sensors were attached to the LMA Supreme/i-Gel at four locations corresponding to the A, base of tongue; B, distal oropharynx; C, hypopharynx; and D, pyriform fossa.

Insertion success rate and oropharyngeal leak pressure were also measured.

Enrollment

30 estimated patients

Sex

Female

Ages

19 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ASA I/II
  • female
  • age 19-65 years

Exclusion criteria

  • < 19 years
  • had a known or predicted difficult airway
  • a body mass index > 35 kg m-2, or
  • were at risk of aspiration

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

30 participants in 2 patient groups

Laryngeal Mask Airway Supreme
Experimental group
Description:
Directly measured mucosal pressures
Treatment:
Device: Laryngeal Mask Airway Supreme
i-Gel
Experimental group
Description:
Directly measured mucosal pressures
Treatment:
Device: i-Gel extraglottic airway device

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems